253 results found. Viewing page 1 of 51.
Go to page . . .
The National Cancer Institute is currently recruiting malignant pleural or peritoneal mesothelioma patients for a phase I clinical trial aimed at patients unable to undergo surgery and who have not responded to standard first-line treatments for ...
Continue Reading...
The GRAIL Company in Menlo Park, California has introduced what it calls a first-of-a-kind multi-cancer early detection test called Galleri. Through advancements in genomics research and DNA sequencing, Galleri has the ability to detect more than 50 ...
Continue Reading...
California has enacted an important legal change impacting the terminally ill, which includes mesothelioma patients, and their family members fighting for justice. Starting in January 2022, a new law will allow surviving family members to collect ...
Continue Reading...
The Lancet Oncology recently published the results of a phase II clinical trial showing Gemcitabine used in line with the antibody Ramucirumab yielded better clinical outcomes for malignant pleural mesothelioma than Gemcitabine used alone. The study ...
Continue Reading...
Here it is! The 10 th annual Walk for Mesothelioma. That’s right, number 10! It is time again to help raise awareness about mesothelioma and remember those still fighting and those that fought valiantly against the disease. See the flyer below. ...
Continue Reading...
253 results found. Viewing page 1 of 51.
Go to page . . .